About

European Society of Endocrinology

European Society of Endocrinology e-Vote system - 2017

Kos-KudlaPresident-elect position – Candidate 2 of 2

Name of Nominee: 
Richard Ross

Nationality:
UK

Current position:
Professor of Endocrinology

Speciality in endocrinology/main field of expertise:
Adrenal and Pituitary

Basic, clinical or both:
Both

FURTHER INFORMATION (pdf)

BIOGRAPHY
Richard Ross trained in medicine at The Royal London Hospital (1974-1979) and in Endocrinology at St Bartholomew's Hospital, London (1983-1988). He was appointed to Sheffield University in 1995 and is Professor of Endocrinology and Head of the Academic Unit of Diabetes, Endocrinology and Metabolism. Richard's research and clinical interests are in pituitary and adrenal disease, transition endocrinology and the late effects of cancer. His research has yielded some 234 papers, 35 granted patents and he has an h-index of: Scopus 44 & WOS 43. He currently has over £3 million in active grants, is Principle Investigator on a £2.4M MRC DPFS grant developing a long-acting growth hormone antagonists and Principle Investigator on a €4.2M EC FP7 project "TAIN" which has successfully developed a new paediatric medicine for the treatment of paediatric adrenal insufficiency.

Richard is the Faculty Academic Lead for Innovation and founding Director of two university spin-out companies; Asterion Ltd developing long-acting growth hormone analogues and Diurnal Ltd developing circadian endocrine therapies. He has served on the editorial boards of: Clinical Endocrinology (1996-2000), Growth & Growth Factors (1986-2006), Endocrinologist (2001-2004), Hormones (2004-), and J Clin Endocrinol Metab (2010-2014). Council member for the Society of Endocrinology (1999-2002), Society for Endocrinology Public Engagement Committee (2008-2011) and Nominations Committee (2010-2012), The Growth Hormone Research Society Council (2011-2016), Executive Committee of the European Society of Endocrinology (2011-2015), and Treasurer of the European Society of Endocrinology (2013-2015).

ELECTION STATEMENT
My vision for ESE is a society that promotes equality of opportunity for all its members, represents the full breadth of endocrinology throughout its activities, publishes the highest impact journals, runs an international congress and educational activities that are of the greatest quality, promotes patient advocacy, lobbies governments on an international scale and has the resources and financial stability to support all its activities. I have been at the heart of the society over the last 5 years and deeply involved in developing its strategy and thus have the experience and skills to deliver on my vision. In 2016 ESE celebrated its 10-year anniversary. The reflections of ESE's past and present presidents in the latest Newsletter captures their pride in the society’s growth as the Voice of European Endocrinology.

I have been a member of ESE since its inception, was elected to the Executive Council, edited the newsletter during its transformation, and was Treasurer from 2012-2015. I share the pride of the four presidents at the Society's success and feel privileged to have served the Society during its rise to the premier league of International Endocrine Societies. Election to President Elect would fulfil my desire to promote and develop ESE.

I believe I can bring my experience in leadership, administration, finance and knowledge exchange to the benefit of ESE through support for endocrine research, education and patient care which have been the focus of my career. I am a passionate European and laid the foundation of the ESE Council of Affiliated Societies (ECAS) which strengthens and feeds the strategy of the Society.

There has been much debate about the EU and its 28 member countries but I would like to stress that ESE is much bigger than the EU with members' from over 90 countries and affiliated societies from over 40 countries and I am committed to opening the society to all those individuals, national societies and affiliated societies that have an interest in hormones. Whilst a member of the Executive Committee I represented the European Young Endocrine Scientists (EYES) and know that the future of our society is in developing, supporting and enthusing our young members. Through promoting excellence in endocrine science and medicine and by providing public information on endocrinology I believe ESE will deliver on its mission to its members.